Total Valuation
Pharmacorp Rx Inc. has a market cap or net worth of C$82.38M. The enterprise value is C$72.45M.
Market CapC$82.38M
Enterprise ValueC$72.45M
Share Statistics
Pharmacorp Rx Inc. has 196,149,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding196,149,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmacorp Rx Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count5
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Pharmacorp Rx Inc. is ―. Pharmacorp Rx Inc.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Pharmacorp Rx Inc. had revenue of ― and earned -470.43K in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income-577.96K
Pretax Income―
Net Income-470.43K
EBITDA-470.43K
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Pharmacorp Rx Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change-12.50%
50-Day Moving Average0.44
200-Day Moving Average0.46
Relative Strength Index (RSI)52.16
Average Volume (3m)110.50K
Important Dates
Pharmacorp Rx Inc. upcoming earnings date is Nov 26, 2026, During Market Hours (Confirmed).
Last Earnings DateAug 20, 2026
Next Earnings DateNov 26, 2026
Ex-Dividend Date―
Financial Position
Pharmacorp Rx Inc. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Pharmacorp Rx Inc. has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Pharmacorp Rx Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Pharmacorp Rx Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Pharmacorp Rx Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast97.10%
EPS Growth Forecast-138.24%